2m 2m 2m 2m 2m 2m 2m
ARCT THERAP HLDG (ARCT)
NASDAQ
$7.35+$0.27 (+3.80%)
Price as of Jun 23, 2026 6:25 PM EDT- $205.5MMarket Cap
- -47.20%1-Year Change
- BiotechnologyIndustry
ARCT THERAP HLDG (ARCT)
$7.35+$0.27 (+3.80%)
ARCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.08 | ||
Change | -$0.15 (-2.07%) | ||
Open | $7.15 | ||
High | $7.42 | ||
Low | $7.05 | ||
Previous Close | $7.23 | ||
Volume | 339,741 | ||
30-Day Average Volume | 371,876 | ||
1-Week Change | -0.84% | ||
1-Month Change | 0.71% | ||
1-Year Change | -47.20% | ||
3-Year Change | -70.43% | ||
5-Year Change | -79.19% | ||
Fundamentals | |||
Shares Outstanding | 28.4M | ||
Total Assets | $245.4M | ||
Market Cap | $205.5M | ||
Enterprise Value | -$5.9M | ||
Period: QTR TTM FY | |||
Revenue | $610,000.00 | ||
Net Income | -$27.0M | ||
Free Cash Flow | -$19.4M | ||
EBIT | -$27.0M | ||
EBITDA | -$26.3M | ||
Net Working Capital | $182.5M | ||
EPS | -$0.95 | ||
Enterprise Value/EBITDA | 0 | ||
Enterprise Value/Revenue | -10 | ||
P/B | 1 | ||
P/E | -8 | ||
PEG | -1 | ||
Price/Free Cash Flow | -11 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue